AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 49 filers reported holding AGILE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $21,000 | -48.8% | 42,200 | 0.0% | 0.00% | – |
| Q3 2021 | $41,000 | -62.7% | 42,200 | -49.0% | 0.00% | – |
| Q2 2021 | $110,000 | -39.6% | 82,800 | -5.6% | 0.00% | – |
| Q1 2021 | $182,000 | +38.9% | 87,736 | +92.9% | 0.00% | – |
| Q4 2020 | $131,000 | +227.5% | 45,491 | +244.9% | 0.00% | – |
| Q3 2020 | $40,000 | -74.7% | 13,191 | -52.4% | 0.00% | – |
| Q4 2016 | $158,000 | -18.6% | 27,730 | 0.0% | 0.00% | – |
| Q3 2016 | $194,000 | -38.0% | 27,730 | -32.6% | 0.00% | – |
| Q2 2016 | $313,000 | – | 41,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 5,062,363 | $13,617,000 | 18.09% |
| CAXTON CORP | 1,820,012 | $4,896,000 | 5.95% |
| Vivo Capital, LLC | 1,513,975 | $4,073,000 | 0.87% |
| Aisling Capital LLC | 1,304,933 | $3,510,000 | 0.69% |
| INVESTOR AB | 3,510,189 | $9,442,000 | 0.62% |
| Perceptive Advisors | 3,380,000 | $9,092,000 | 0.30% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 408,838 | $1,099,000 | 0.29% |
| Broadfin Capital, LLC | 358,295 | $964,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 63,744 | $171,000 | 0.03% |
| Monashee Investment Management LLC | 16,411 | $44,000 | 0.02% |